April 30, 2004 An Open Letter to Officials of the National Institute of Mental HealthALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org From: Vera Hassner Sharav, President Read More An Open Letter to Officials of the National Institute of Mental Health
April 26, 2004 Associated Press: More Details about FDA Warning Strattera Associated with SuicideAssociated Press: More Details about FDA Warning Strattera Associated with Suicide Thu, 29 Sep 2005 On April Read More Associated Press: More Details about FDA Warning Strattera Associated with Suicide
April 26, 2004 VIOXX – Merck–MEDCO – a case studyVIOXX – Merck–MEDCO – a case study Wed, 13 Oct 2004 Vioxx: A case study in how Read More VIOXX – Merck–MEDCO – a case study
April 20, 2004 Tell the Truth About Antidepressants On Drug Labels & in Medical JournalsTell the Truth About Antidepressants On Drug Labels & in Medical Journals Thu, 16 Sep 2004 An Read More Tell the Truth About Antidepressants On Drug Labels & in Medical Journals
April 19, 2004 NIH Rule change Re: Whistle blowers – Comments due before June 15NIH Rule change Re: Whistle blowers – Comments due before June 15 Mon, 19 Apr 2004 Dear Read More NIH Rule change Re: Whistle blowers – Comments due before June 15